RCPHARM: what changed
What changed
RCPHARM
NACE 64.210, Activities of holding companies
filed annual accounts (NBB)
Net result for the year
€245,245
2024 · €148,204+€97,041
Equity
€997,212
2024 · €751,967+€245,245
Cash
€4,832
2024 · €8,152-€3,320
Balance sheet total
€2.2m
2024 · €2.2m+€890
Largest movements
Assets
No asset line moved by more than 1% of the balance sheet total.
Equity and liabilities
- Profit (loss) carried forward +€245,245
up €245,245 (+41.4%), from €592,813 to €838,058
- Other debts -€116,261
down €116,261 (-11.8%), from €988,986 to €872,725
- Debts after one year -€87,272
down €87,272 (-28.1%), from €310,703 to €223,431
- Current portion of long-term debt -€37,687
down €37,687 (-29.6%), from €127,454 to €89,767
Income statement
- Financial income +€97,000
up €97,000 (+84.3%), from €115,000 to €212,000
- Financial charges +€6,611
up €6,611 (+139%), from €4,757 to €11,368
- Gross operating margin +€4,197
up €4,197 (+8.0%), from €52,506 to €56,704
- Taxes -€3,003
down €3,003 (-21.1%), from €14,231 to €11,228
- Depreciation +€718
up €718 (+3,903%), from €18 to €737
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Result 2024
€148,204
Gross operating margin
+€4,197
Depreciation
-€718
Other operating charges
+€169
Financial income
+€97,000
Financial charges
-€6,611
Taxes
+€3,003
Result 2025
€245,245
raises the resultlowers the result
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
From operations
+€124,771
Investment
-€3,132
Financing
-€124,959
Cash 2024
€8,152
From operations (derived)
+€124,771
Net result for the year
+€245,245
Depreciation
+€737
Receivables within one year
-€2,948
Deferred charges and accrued income
+€1,134
Trade debts
-€2,637
Tax, wage and social debts
-€498
Other debts
-€116,261
Investment (derived)
-€3,132
Investment in fixed assets (net)
-€3,132
Financing
-€124,959
Debts after one year
-€87,272
Current portion of long-term debt
-€37,687
Cash 2025
€4,832
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,186,075 | €2,186,966 | +€890 | 0.0% |
| Fixed assets | 21/28 | €2,172,111 | €2,174,506 | +€2,395 | +0.1% |
| Tangible fixed assets | 22/27 | €2,086 | €4,506 | +€2,420 | +116% |
| Plant, machinery and equipment | 23 | €2,086 | €4,506 | +€2,420 | +116% |
| Financial fixed assets | 28 | €2,170,025 | €2,170,000 | -€25 | 0.0% |
| Current assets | 29/58 | €13,964 | €12,459 | -€1,505 | -10.8% |
| Amounts receivable within one year | 40/41 | €3,785 | €6,733 | +€2,948 | +77.9% |
| Other amounts receivable | 41 | €3,785 | €6,733 | +€2,948 | +77.9% |
| Cash at bank and in hand | 54/58 | €8,152 | €4,832 | -€3,320 | -40.7% |
| Deferred charges and accrued income | 490/1 | €2,028 | €894 | -€1,134 | -55.9% |
| Total equity and liabilities | 10/49 | €2,186,075 | €2,186,966 | +€890 | 0.0% |
| Equity | 10/15 | €751,967 | €997,212 | +€245,245 | +32.6% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Revaluation surpluses | 12 | €136,154 | €136,154 | = | 0.0% |
| Reserves | 13 | €3,000 | €3,000 | = | 0.0% |
| Non-distributable reserves | 130/1 | €3,000 | €3,000 | = | 0.0% |
| Reserves not available under the articles | 1311 | €3,000 | €3,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €592,813 | €838,058 | +€245,245 | +41.4% |
| Amounts payable | 17/49 | €1,434,109 | €1,189,754 | -€244,355 | -17.0% |
| Amounts payable after more than one year | 17 | €310,703 | €223,431 | -€87,272 | -28.1% |
| Financial debts | 170/4 | €310,703 | €223,431 | -€87,272 | -28.1% |
| Amounts payable within one year | 42/48 | €1,123,406 | €966,323 | -€157,083 | -14.0% |
| Current portion of amounts payable after more than one year | 42 | €127,454 | €89,767 | -€37,687 | -29.6% |
| Trade debts | 44 | €2,851 | €214 | -€2,637 | -92.5% |
| Suppliers | 440/4 | €2,851 | €214 | -€2,637 | -92.5% |
| Taxes, remuneration and social security | 45 | €4,115 | €3,617 | -€498 | -12.1% |
| Taxes | 450/3 | €4,115 | €3,617 | -€498 | -12.1% |
| Other amounts payable | 47/48 | €988,986 | €872,725 | -€116,261 | -11.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €18 | €737 | +€718 | +3,903% |
| Other operating charges | 640/8 | €295 | €126 | -€169 | -57.2% |
| Gross operating margin | 9900 | €52,506 | €56,704 | +€4,197 | +8.0% |
| Operating profit (loss) | 9901 | €52,193 | €55,841 | +€3,648 | +7.0% |
| Financial income | 75/76B | €115,000 | €212,000 | +€97,000 | +84.3% |
| Recurring financial income | 75 | €115,000 | €212,000 | +€97,000 | +84.3% |
| Financial charges | 65/66B | €4,757 | €11,368 | +€6,611 | +139% |
| Recurring financial charges | 65 | €4,757 | €11,368 | +€6,611 | +139% |
| Profit (loss) for the period before taxes | 9903 | €162,436 | €256,473 | +€94,037 | +57.9% |
| Income taxes | 67/77 | €14,231 | €11,228 | -€3,003 | -21.1% |
| Profit (loss) for the period | 9904 | €148,204 | €245,245 | +€97,041 | +65.5% |
| Profit (loss) for the period to be appropriated | 9905 | €148,204 | €245,245 | +€97,041 | +65.5% |
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Compare this company with its sector.Sector benchmark
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 3 November 2026 via checked.be.